PH30761A - An infant formulation fortified with bile salt-activated lipase. - Google Patents

An infant formulation fortified with bile salt-activated lipase.

Info

Publication number
PH30761A
PH30761A PH43285A PH43285A PH30761A PH 30761 A PH30761 A PH 30761A PH 43285 A PH43285 A PH 43285A PH 43285 A PH43285 A PH 43285A PH 30761 A PH30761 A PH 30761A
Authority
PH
Philippines
Prior art keywords
bssl
fortified
bile salt
sequence given
activated lipase
Prior art date
Application number
PH43285A
Other languages
English (en)
Inventor
Bjursell Gunner
Blackberg Lars
Olivecrona Thomas
Herell Olle
Carlson Peter
Nilsson Jeanette
Enerback Sven
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PH30761A publication Critical patent/PH30761A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH43285A 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase. PH30761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products

Publications (1)

Publication Number Publication Date
PH30761A true PH30761A (en) 1997-10-17

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43285A PH30761A (en) 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase.

Country Status (44)

Country Link
EP (1) EP0535048B1 (fr)
JP (1) JPH05507201A (fr)
KR (1) KR100212411B1 (fr)
CN (2) CN1075113C (fr)
AP (1) AP207A (fr)
AT (1) ATE151077T1 (fr)
AU (1) AU651979B2 (fr)
BG (1) BG61165B1 (fr)
CA (1) CA2083396C (fr)
CZ (1) CZ287470B6 (fr)
DE (1) DE69125489T2 (fr)
DK (1) DK0535048T3 (fr)
DZ (1) DZ1503A1 (fr)
EG (1) EG19937A (fr)
ES (1) ES2099159T3 (fr)
FI (1) FI114639B (fr)
GR (1) GR3023618T3 (fr)
HK (1) HK62497A (fr)
HR (1) HRP920771B1 (fr)
HU (1) HU215258B (fr)
IE (1) IE911844A1 (fr)
IL (1) IL98273A (fr)
IS (1) IS1751B (fr)
JO (1) JO1694B1 (fr)
LT (1) LT4020B (fr)
LV (1) LV10292B (fr)
MA (1) MA22166A1 (fr)
MY (1) MY111245A (fr)
NO (1) NO322962B1 (fr)
NZ (1) NZ238223A (fr)
PH (1) PH30761A (fr)
PL (1) PL166534B1 (fr)
PT (1) PT97836B (fr)
RO (1) RO114793B1 (fr)
RU (1) RU2140983C1 (fr)
SE (1) SE9001985D0 (fr)
SG (1) SG48078A1 (fr)
SK (1) SK281089B6 (fr)
TN (1) TNSN91041A1 (fr)
TW (1) TW221712B (fr)
UA (1) UA39165C2 (fr)
WO (1) WO1991018923A1 (fr)
YU (1) YU49138B (fr)
ZA (1) ZA913778B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616483A (en) * 1992-06-11 1997-04-01 Aktiebolaget Astra Genomic DNA sequences encoding human BSSL/CEL
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
EP1963524A2 (fr) * 2005-12-01 2008-09-03 University of Bergen Diagnostic et traitement des dysfonctionnements de l'exocrine pancreas et des diabetes
MX338426B (es) 2010-04-23 2016-04-15 Synageva Biopharma Corp Enzima de enfermedad del almacenamiento lisosomico.
DK2613798T4 (en) 2010-09-09 2018-04-16 Synageva Biopharma Corp USING LYSOSOMAL SUR LIPASE TO TREAT PATIENTS WITHOUT LYSOSOMAL SUR LIPASE
CA2812852A1 (fr) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Procede pour augmenter l'absorption d'acides gras insatures par des nourrissons humains
DK2629790T3 (en) * 2010-10-21 2016-10-24 Swedish Orphan Biovitrum Ab (Publ) Approach to increase growth rate of human babies
KR20200018781A (ko) * 2017-06-19 2020-02-20 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) 반감기 연장 폴리펩티드를 갖는 융합 단백질
MX2022002473A (es) 2019-08-30 2022-08-02 Codexis Inc Variantes de lipasa modificadas geneticamente.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3107684A (en) * 1983-07-01 1985-02-07 Celltech Limited Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production

Also Published As

Publication number Publication date
EP0535048B1 (fr) 1997-04-02
HU215258B (hu) 1998-11-30
HRP920771B1 (en) 1999-10-31
AP9100270A0 (en) 1991-07-31
SK164491A3 (en) 1995-07-11
SE9001985D0 (sv) 1990-06-01
RO114793B1 (ro) 1999-07-30
GR3023618T3 (en) 1997-08-29
IL98273A0 (en) 1992-06-21
IL98273A (en) 2005-11-20
EP0535048A1 (fr) 1993-04-07
NO924528D0 (no) 1992-11-24
CN1326782A (zh) 2001-12-19
HUT63184A (en) 1993-07-28
NZ238223A (en) 1993-05-26
JO1694B1 (en) 1992-08-09
FI925453L (fi) 1992-11-30
LTIP1736A (en) 1995-08-25
IE911844A1 (en) 1991-12-04
NO924528L (no) 1992-11-24
HRP920771A2 (en) 1997-04-30
DE69125489T2 (de) 1997-08-14
BG97123A (bg) 1993-12-24
HK62497A (en) 1997-05-16
CA2083396A1 (fr) 1991-12-02
PT97836A (pt) 1992-02-28
CN1075113C (zh) 2001-11-21
CZ287470B6 (cs) 2000-12-13
DZ1503A1 (fr) 2004-09-13
FI925453A0 (fi) 1992-11-30
TNSN91041A1 (fr) 1992-10-25
KR100212411B1 (en) 1999-08-02
AU7964591A (en) 1991-12-31
ES2099159T3 (es) 1997-05-16
CZ164491A3 (cs) 1999-07-14
PT97836B (pt) 1998-11-30
NO322962B1 (no) 2006-12-18
BG61165B1 (bg) 1997-01-31
WO1991018923A1 (fr) 1991-12-12
SK281089B6 (sk) 2000-11-07
TW221712B (fr) 1994-03-11
ATE151077T1 (de) 1997-04-15
SG48078A1 (en) 1998-04-17
IS1751B (is) 2000-07-21
DK0535048T3 (da) 1997-09-29
UA39165C2 (uk) 2001-06-15
EG19937A (en) 2000-12-31
PL166534B1 (pl) 1995-05-31
RU2140983C1 (ru) 1999-11-10
CN1064313A (zh) 1992-09-09
JPH05507201A (ja) 1993-10-21
ZA913778B (en) 1992-02-26
CA2083396C (fr) 2006-09-19
LV10292B (en) 1995-08-20
AP207A (en) 1992-08-18
YU49138B (sh) 2004-03-12
FI114639B (fi) 2004-11-30
AU651979B2 (en) 1994-08-11
MY111245A (en) 1999-10-30
HU9203774D0 (en) 1993-03-29
IS3710A7 (is) 1991-12-02
MA22166A1 (fr) 1991-12-31
DE69125489D1 (de) 1997-05-07
YU95191A (sh) 1994-06-10
LV10292A (lv) 1994-10-20
LT4020B (en) 1996-08-26

Similar Documents

Publication Publication Date Title
NZ238223A (en) Human bile salt-stimulated lipase related proteins and their production and use
WO1998014592A3 (fr) Transcriptase inverse de la telomerase
CA2144312A1 (fr) Acides aliphatiques dicarboxyliques non satures
ZA957321B (en) Nucleotide sequences of canola and soybean palmitoylacp thioesterase genes and their use in the regulation of fatty acid content of the oils of soybean and canola plants.
DE3787655D1 (de) Microorganismen and plasmide fuer die 2,4-dichlorphenoxyessigsaeure (2,4-d)-monooxigenase - bildung und verfahren zur herstellung dieser plasmide und staemme.
CA2278028A1 (fr) Procede d'amelioration de l'efficacite de transformation
EP0166522A3 (en) Cosmetic preparation
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
AU2670495A (en) Ifn-beta liquid formulations
PL350165A1 (en) Detergent cosmetic compositions and use
IE873239L (en) Variants of hirudin
EP0293766A3 (fr) Emulsions
EP1591528A3 (fr) Procedes et compositions pour l'administration et l'expression d'acides nucleiques codant l'interferon alpha
EP0317279A3 (fr) Peptides pour l'usage dans la purification du facteur-VIII
CA2293367A1 (fr) Esters de cire enrichis en acides gras .omega.-3 insatures, leur preparation et leur utilisation
CA2216004A1 (fr) Compositions d'adjuvant de rincage ameliorees contenant des esters phosphoriques
Kubicki et al. THEORETICAL BASES OF PHOSPHOROORGANIC INHIBITORS USING IN NEUTRAL WATER SYSTEMS(Polish)
WO2001012663A3 (fr) Facteurs de regulation hematopoietique et procedes d'utilisation
Torma Edward Albee’s Tiny Alice: alienation and desire in the religious subject
WO2001036458A3 (fr) Homologue ced-6 de la drosophile
IT8820978A0 (it) Composizione erbicida conselettivita' aumentata e processo per la preparazione di entrambi i componenti ingredienti attivi in un solo stadio.
IT8422818A0 (it) Procedimento di verniciatura decorativa di manufatti in legno e prodotti cosi' ottenuti.
IT1216383B (it) Metodo per adornare oggetti metallici,in particolare oggetti decorativi per arte funeraria o per la casa, e oggetti cosi'ottenuti
RU99114027A (ru) Нуклеиново-кислотные и аминокислотные последовательности helicobacter pylory и их вакцинные композиции
HUT52570A (en) Polishing and stabilizing composition for sulphur-acid-hydrogene-peroxid pickling of copper and copper-alloys